Accepted for/Published in: JMIR Research Protocols
Date Submitted: Nov 4, 2020
Date Accepted: Dec 1, 2020
Date Submitted to PubMed: Dec 8, 2020
The impact of telemedicine use by oncology physicians on the patient and informal caregiver experience of receiving care: a scoping review protocol in the context of COVID-19
ABSTRACT
Background:
Information needs are frequently identified as one of the most commonly unmet supportive care needs in the cancer population. During the COVID-19 pandemic, the use of telemedicine by oncology physicians in Manitoba, Canada has increased to limit the risk of the virus to both patients and healthcare providers. It is not clear how telemedicine impacts the information needs or experience of receiving cancer care.
Objective:
The objective of this study is to describe how the use of telemedicine impacts the information needs and experience of cancer patients and their informal caregivers (i.e. friends/family) and identify directions for future research.
Methods:
The objective of this study is to describe how the use of telemedicine impacts the information needs and experience of cancer patients and their informal caregivers (i.e. friends/family) and identify directions for future research. This review will include all studies addressing telemedicine in the cancer context including those utilizing quantitative, qualitative, and mixed methods approaches.
Results:
Results from this review are expected to be available within the next 6 - 8 months.
Conclusions:
This scoping review will assist both clinicians and researchers in developing and implementing strategies to improving both the experience of receiving and delivering oncology care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.